Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders
Measurement of exhaled nitric oxide is considered investigational in the diagnosis and management of asthma, eosinophilic asthma and other respiratory disorders, including chronic obstructive pulmonary disease and chronic cough. Measurement of exhaled breath condensate is considered investigational in the diagnosis and management of asthma and other respiratory disorders, including chronic obstructive pulmonary disease and chronic cough. For Federal Employee Program members, devices approved for marketing by the FDA may not be considered investigational and may be assessed only on the basis of medical necessity. The 12/02/2025 review made no changes to the policy statements.